The global poultry vaccine market is estimated to be valued at US$1,766.8 Mn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023-2030, according to a new report published by Coherent Market Insights.

Market Overview:
The poultry vaccine market comprises vaccines developed specifically for the prevention and control of diseases in poultry. These vaccines play a crucial role in maintaining the health and productivity of poultry farms, reducing economic losses due to disease outbreaks. The need for poultry vaccines stems from the high susceptibility of poultry to various infectious diseases, such as avian influenza, Newcastle disease, and infectious bronchitis. Vaccination helps poultry farmers safeguard their flocks and prevent the spread of disease, ensuring a steady supply of safe and healthy poultry products.

Market Key Trends:
One key trend shaping the poultry vaccine market is the increasing demand for disease prevention in poultry. With the growing concern over food safety and the need to meet global protein demands, poultry farmers are focusing on preventive healthcare measures, including vaccination. Poultry vaccines help protect birds from diseases, reducing the reliance on antibiotics and enhancing overall flock health. Additionally, increasing government initiatives and awareness programs regarding vaccination are further driving the adoption of poultry vaccines. The trend of disease prevention through vaccination is expected to fuel the growth of the poultry vaccine market during the forecast period.


PEST Analysis:
Political: The political landscape plays a crucial role in the poultry vaccine market. Government regulations on animal health and vaccination programs have a significant impact on the market. Political stability in various regions can also influence market growth.

Economic: The economic factors that affect the poultry vaccine market include disposable income, GDP growth, and inflation rates. Higher disposable income allows individuals to invest more in their pets and livestock, leading to increased demand for poultry vaccines. Economic growth in emerging markets can create new opportunities for market expansion.

Social: Social factors that impact the poultry vaccine market include changing consumer preferences, awareness about animal health, and the increasing demand for quality and safe poultry products. Growing concerns about diseases transmitted from animals to humans also drive the demand for vaccines.

Technological: Technological advancements in vaccine manufacturing, such as improved production methods and innovative formulations, have had a positive impact on market growth. Automation and digitization of processes have also improved efficiency and reduced costs in the poultry vaccine industry.

Key Takeaways:
The Global Poultry Vaccine Market Demand is expected to witness high growth, exhibiting a CAGR of 7.9% over the forecast period (2023-2030), due to increasing awareness about animal health and the rising demand for safe and quality poultry products. The market size is projected to reach US$ 1,766.8 million by 2023.

In terms of regional analysis, Asia Pacific is anticipated to be the fastest-growing and dominating region in the poultry vaccine market. The increasing consumption of meat and eggs, coupled with rising poultry production, is driving the demand for vaccines in the region. Additionally, government initiatives to improve animal health and prevent diseases are further supporting market growth.

Key players operating in the poultry vaccine market include Zoetis Inc., Merck & Co. Inc., Elanco, Ceva Santé Animale, Boehringer Ingelheim, Biovac, Hester Biosciences Limited, Dechra Pharmaceuticals PLC, Venky’s Limited, and Phibro Animal Health Corporation, among others. These key players focus on product innovation, strategic partnerships, and mergers and acquisitions to gain a competitive edge in the market.

Read more: https://www.ukwebwire.com/poultry-vaccine-market-size-trends/